These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3999928)

  • 1. Chylomicron-like particles in severe hypertriglyceridemia.
    Aviram M; Sechter Y; Brook JG
    Lipids; 1985 Apr; 20(4):211-5. PubMed ID: 3999928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lipoprotein and platelet function after heparin injection: studies in normal fasted and postprandial and in type V hyperlipoproteinemic subjects.
    Aviram M; Rosenblat M; Potesman M; Dankner G; Brook JG
    Biochem Med Metab Biol; 1986 Jun; 35(3):279-92. PubMed ID: 3718760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chylomicronaemia in multiple myeloma.
    Aviram M; Carter A; Brook JG; Tatarsky I
    Scand J Haematol; 1985 May; 34(5):436-41. PubMed ID: 4012223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial plasma lipoproteins in normal and hypertriglyceridaemic subjects and their in vitro effect on platelet activity: differences between saturated and polyunsaturated fats.
    Aviram M; Fuhrman B; Brook JG
    Scand J Clin Lab Invest; 1986 Oct; 46(6):571-9. PubMed ID: 3775243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipoprotein pattern and decreased platelet function in type V hyperlipoproteinemia.
    Aviram M; Brook JG
    Isr J Med Sci; 1985 Nov; 21(11):898-904. PubMed ID: 4077486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.
    Weintraub MS; Eisenberg S; Breslow JL
    J Clin Invest; 1987 Apr; 79(4):1110-9. PubMed ID: 3470306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postchallenge plasma lipoprotein retinoids: chylomicron remnants in endogenous hypertriglyceridemia.
    Wilson DE; Chan IF; Buchi KN; Horton SC
    Metabolism; 1985 Jun; 34(6):551-8. PubMed ID: 3999977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slower catabolism of apo B48 than of apo B100 in triglyceride-rich lipoproteins during heparin infusions in type 5 hyperlipoproteinemic subjects.
    Nestel P; Billington T
    Metabolism; 1987 Feb; 36(2):172-5. PubMed ID: 3807788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chylomicrons from patients with type V hyperlipoproteinemia inhibit platelet function.
    Aviram M; Furman B; Brook JG
    Atherosclerosis; 1985 Aug; 56(2):157-67. PubMed ID: 4074453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial type V hyperlipoproteinemia with hyper-remnant-like particle-cholesterol accompanied with apolipoprotein E3/E4 phenotype.
    Nagai T; Tomizawa T; Saito T; Nakano T; Nakajima K; Mori M
    Intern Med; 1996 May; 35(5):388-91. PubMed ID: 8797053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of chylomicron remnant clearance in normal and in hyperlipoproteinemic subjects.
    Cortner JA; Coates PM; Le NA; Cryer DR; Ragni MC; Faulkner A; Langer T
    J Lipid Res; 1987 Feb; 28(2):195-206. PubMed ID: 3572247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased platelet aggregation during alimentary hyperlipemia in normal and hypertriglyceridemic subjects.
    Fuhrman B; Brook JG; Aviram M
    Ann Nutr Metab; 1986; 30(4):250-60. PubMed ID: 3752924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
    Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
    Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.
    Packard CJ; Munro A; Lorimer AR; Gotto AM; Shepherd J
    J Clin Invest; 1984 Dec; 74(6):2178-92. PubMed ID: 6511922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of hypertriglyceridemia.
    Schaefer EJ; McNamara JR; Genest J; Ordovas JM
    Semin Thromb Hemost; 1988 Apr; 14(2):143-8. PubMed ID: 3061000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary chylomicronemia in patients with severe familial hypertriglyceridemia responds to long-term treatment with (n-3) fatty acids.
    Pschierer V; Richter WO; Schwandt P
    J Nutr; 1995 Jun; 125(6):1490-4. PubMed ID: 7782902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human intestinal lipoproteins. Studies in chyluric subjects.
    Green PH; Glickman RM; Saudek CD; Blum CB; Tall AR
    J Clin Invest; 1979 Jul; 64(1):233-42. PubMed ID: 221544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.